Status:
COMPLETED
GABA and Beta-cell Regeneration
Lead Sponsor:
Ministry of Health and Population, Egypt
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18-25 years
Brief Summary
GABA(gamma-Aminobutyric acid) may be used for decreasing anti-gad antibodies and leads beta-cell regeneration.
Detailed Description
100 patients with type I diabetes were in 2 groups, had been monitored in a private clinic, number 50 each group, with 30 females and 20 males after the written consent of all patients. All the patie...
Eligibility Criteria
Inclusion
- \- type 1 diabetes patients age from 18 to 25 years on basal bolus insulin
Exclusion
- thyroid problems liver disease kidney disease
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 2 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04375020
Start Date
November 1 2019
End Date
May 2 2020
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud Younis
Cairo, Egypt, 11865